4Juhlin L. Inhibition of cold urticaria by desloratadine[ J]. J Dermatol Treat, 2004,15( 1 ) :51 - 59,.
5Ten Eick AP, Blumer JL, Reed MD. Safety of antihistamines in children[J]. Drug Saf, 2001,24(2) : 119 - 147.
6Anthes JC, Richard C, West RE, et al. Functional characterization of desloratadine and other antihistamines in humane H1 receptors [J].Allergy, 2000,55 ( Suppl 63 ) : S279.
7Lippert U, Moiler A, welker P, et al. Inhibition of cytokine secretion from human leukemic mast cells and basophilis by H1 and H2 receptor antagonists[J]. Exp Dermatol,2000,9(2) : 118 - 124.
8Bloom M, Staudinger H, Herron J. Safety of desloratadine syrup in children[J]. Curr Med Res Opin ,2004,20(12) : 1959 - 1965.
9Banfield C,Gupta S, Marino M, et al. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine [ J]. Clin Pharmacokinet, 2002,41 (4) : 311 - 318.
10Bachert C. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis [ J ]. Allergy, 2001,56 ( Suppl 65 ) : S14 - S20.